Constellation Software (CSU) Q2 2026 earnings summary

Executive summary

• AI adoption is accelerating across business units, improving development productivity and enabling faster product enhancements, though no immediate impact on organic growth is seen yet.

• Revenue for Q2 2026 rose 17% year-over-year to $3,335 million, with organic growth of 3% (1% after FX adjustment).

• Net income attributable to common shareholders surged 386% to $274 million ($12.93 per diluted share), mainly due to FX and IRGA liability revaluation; excluding these, net income increased 8%.

• Multiple large acquisitions were completed for $732 million in cash, with total consideration (including deferred payments) of $893 million, driven by long-term relationship building.

• The company remains focused on software, with no current plans to diversify outside vertical market software.

Outlook and guidance

• Organic growth is expected to normalize to historical levels (~5%) as recent one-off impacts from large contracts and customer attrition subside.

• No significant customer losses or unusual events are anticipated in the near term based on the current portfolio.

• Forward-looking statements highlight significant risks and uncertainties, with no guarantees of future performance.

• M&A pipeline remains strong, but deal timing is unpredictable; focus remains on being ready to act when opportunities arise.

Segment performance

• Altera's organic maintenance and recurring revenue growth decelerated due to prior strong quarters and accounting effects; the business is expected to be a slow shrinker over the next couple of years.

• Lumine and other recent acquisitions have shown low or negative organic growth due to transitional issues, but are expected to improve.